MACKENZIE WELCH: Open Payments
NPI 1174369441 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,033 in 55 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $688 · 2025 $1,033
Food & beverage: $1,033
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $230 |
| ABBVIE INC. | 13 | $224 |
| Otsuka America Pharmaceutical, Inc. | 6 | $109 |
| Vanda Pharmaceuticals Inc. | 3 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| UCB, Inc. | 2 | $41 |
| Astellas Pharma US Inc | 2 | $33 |
| Corcept Therapeutics | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
Products named: NURTEC ODT, UBRELVY, REXULTI, HETLIOZ, VRAYLAR, CAPLYTA, Kerendia, Briviact.
Industry payments across KY — which companies pay providers there.
